International Vaccine Access Center
Featured
Tracking Measles Cases in the U.S.
Measles outbreaks have been reported in multiple states, highlighting the importance of measles vaccination and rapid detection and reporting of suspected and confirmed measles cases.
Measles in America: Causes, Risks, and Responses
Watch our April 2025 webinar exploring the causes, risks, and responses to an increasing number of measles cases in the United States and featuring a panel of distinguished experts.
New WHO Recommendations to Protect Infants from RSV
The WHO recently published its first-ever position paper outlining recommendations to protect infants against RSV, the leading cause of acute lower respiratory infections in children.
Accelerating global access to life-saving vaccines.
We apply rigorous science to build knowledge and support for the value of vaccines.
IVAC's Work
The International Vaccine Access Center accelerates equitable and sustainable access to vaccines in low- and middle-income countries by generating, synthesizing, and using evidence to inform decision making and action.
Where We Work
IVAC works with governments and major research institutions in 38 countries. Learn more about us.
What We Do: Project Highlights
Vaccine Information and Epidemiology Window (VIEW-HUB)
VIEW-hub is IVAC’s publicly accessible interactive platform to visualize real-time information on vaccine use, product type, coverage levels, impact assessments, and disease burden estimates. It can be utilized to track progress and strategize ways to accelerate and optimize vaccine implementation.
READ MORE>
Vaccine Economics Research for Sustainability & Equity (VERSE)
VERSE will compute the economic benefits and return-on-investment of vaccines, create a standardized model for assessing, tracking, and targeting vaccine coverage inequity at the country level and for monetizing the economic losses due to inequity, and more.
READ MORE >
Stay Connected
Sign up for our monthly newsletter to receive the latest updates on immunization-related science, policy, and access from the International Vaccine Access Center at the Johns ÎÚÑ»´«Ã½.